Is ASKA Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, ASKA Pharmaceutical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY25 per share. Over the last 7 times between 2021 and 2024, ASKA Pharmaceutical has paid JPY95 with an average of JPY13.57 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for ASKA Pharmaceutical 10 years ago, but if you had invested on Thursday 1st of April 2021 when the price was JPY1 461.00, you would have made a profit of JPY800.00 per share or 54.76%
Yes, the average daily trading liquidity for ASKA Pharmaceutical is JPY63 052 thousand. You should therefore be able to get in and out of your positions relatively fast.
ASKA Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.44, the company's ability to pay off the debt is normal. ASKA Pharmaceutical has a good net profit margin of 12.01% and should have high tolerances against inflation.
We have calculated the inflation risk for ASKA Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.